Summary
In vivo microdialysis in freely moving rats was used to study the biotransformation, consisting primarily of decarboxylation by aromatic amino acid decarboxylase (AAAD), of the precursors L-3,4-dihydroxyphenylalanine (L-DOPA), L-5-hydroxytryptophan (L-5HTP), and L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) on extracellular levels of dopamine (DA), serotonin (5HT) and noradrenaline (NA), respectively. The precursors were administered locally through the microdialysis probe into the striatum and into the hippocampus. The different transmitter systems were compared with respect to the ability of the precursors to elevate extracellular levels of their associated transmitter.
The basal extracellular concentrations of NA and DA were found to be tetrodotoxin (TTX, a blocker of fast sodium channels) sensitive in striatum and hippocampus, indicating the neuronal origin of the measured transmitters. The extracellular concentrations of 5HT (in hippocampus) were only 60% TTX-sensitive. L-DOPA and L-5HTP showed to be effective precursors of DA and 5HT, respectively, although their formation profile was quite different. The L-DOPA-induced increase in extracellular DA was large and short-lasting, while the L-5HTP-induced increase in 5HT was slower and less pronounced. The relative increase in extracellular DA or 5HT was more pronounced in the brain region where their baseline values were lower, but the absolute amount of transmitter formed from their precursor was similar in both brain regions. L-threo-DOPS was a poor precursor for NA and also failed to influence extracellular DA in striatum, questioning its use in the treatment of freezing gait in late stages of Parkinson's disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abercrombie ED, Keller RW, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioural studies. Neuroscience 27: 897–904
Aston-Jones G (1985) Behavioral functions of locus coeruleus derived from cellular attributes. Physiol Psychol 13: 118–126
Auerbach SB, Minzenberg MJ, Wilkinson LO (1989) Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanaesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection-dialysate serotonin reflects neuronal release. Brain Res 499: 281–290
Bartholini G, Constantinidis J, Puig M, Tissot R, Pletscher A (1975) The stereo-isomers of 3,4-dihydroxyphenylserine as precursor of norepinephrine. J Pharmacol Exp Ther 193: 523–532
Blaschko H, Chrusciel TL (1960) The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice. J Physiol 151: 272–284
Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 2. Elsevier, Amsterdam, pp 55–122
Byerley WF, Risch SC (1985) Depression and serotonin metabolisms: rationale for neurotransmitter precursor treatment. J Clin Psychopharmacol 5: 191–206
Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely moving rats. Neuroscience 32: 37–645
Dahlström A, Fuxe K (1964) Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiol Scand 62 [Suppl 232]: 1–55
Di Chiara G (1990) In vivo brain dialysis of neurotransmitters. Trends Pharmacol Sci 11: 116–121
Ehringer H, Hornykiewicz O (1960) Verteilung Noradrenalin und Dopamin im Gehirm des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin Wochenschr 72: 1236–1239
Grahame-Smith DG (1974) How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function? Adv Biochem Psychopharmacol 10: 83–87
Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18: 925–962
Jones BE, Moore RY (1977) Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127: 23–53
Klawans Jr HL, Goetz C, Westeimer R (1972) Pathophysiology of schizophrenia and the striatum. Dis Nerv Syst 33: 711–719
Kreiss DS, Wieland S, Lucki I (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52: 295–301
Kuhn DM, Wolf WA, Youdim MBH (1986) Review: serotonin neurochemistry revisited: a new look at some old axioms. Neurochem Int 8: 141–154
L'Heureux R, Dennis T, Curet O, Scatton B (1986) Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J Neurochem 46: 1794–1801
Maruyama W, Nakahara D, Naoi M (1994) A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis. J Neural Transm [P-D Sect] 7: 21–33
Maruyama W, Naoi M, Narabayashi H (1996) The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. J Neurol Sci 139: 141–148
Matsumoto M, Yoshioka M, Togashi H, Hirokami M, Tichihara M, Ikeda T, Smith CB, Saito H (1994) Mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis. Brain Res 636: 1–8
Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2: 19–76
Narabayashi H (1984) Akinesia in parkinsonism — clinical and pharmacological analysis of parkinsonian symptoms. Bull Acad Med Bel 139: 309–320
Narabayashi H, Kondo T, Hayashi A, Suzuki T, Nagatsu T (1981) L-Threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc Jpn Acad Ser B 57: 351–354
Narabayashi H, Kondo T, Yokochi F, Nagatsu T (1986) Clinical effects of L-threo-3,4-dihydroxyphenyl serine in cases of Parkinsonism and pure akinesia. In: Yahr MD, Bergman KJ (eds) Advances in neurology 45. Raven Press, New York, pp 593–602
Pickel VM, Segal M, Bloom FE (1974) A autoradiographic study of the efferent pathways of the nucleus locus coeruleus. J Comp Neurol 155: 15–42
Sarre S, Herregodts P, Deleu D, De Klippel N, Ebinger G, Michotte Y (1992a) High-Performance Liquid Chromatography with electrochemical detection for the determination of levodopa, catecholamines and their metabolites in rat brain dialysates. J Chromatogr Biomed Appl 575: 207–212
Sarre S, Marvin CA, Ebinger G, Michotte Y (1992b) Microbore liquid chromato graphy with electrochemical detection for the determination of serotonin and 5-hydroxyindoleacetic acid in rat brain dialysates. J Chromatogr Biomed Appl 582: 29–34
Sarre S, Herregodts P, Ebinger G, Michotte Y (1994) Biotransformation of locally applied L-DOPA in striatum of hemi-Parkinson rats studied with microdialysis. Naunyn Schmiedebergs Arch Pharmacol 350: 15–21
Sarre S, Ebinger G, Michotte Y (1996) Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists. Eur J Pharmacol 296: 247–260
Sharp T, Bramwell SR, Clark D, Grahame-Smith DG (1989) In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem 53: 234–240
Smolders I, Khan GM, Manil J, Ebinger G, Michotte Y (1997) NMDA-receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats using microdialysis. Br J Pharmacol 121: 1171–1179
Sumi C, Ichinose H, Nagatsu T (1990) Characterization of recombinant human aromatic L-amino acid decarboxylase expressed in COS cells. J Neurochem 55: 1075–1078
Thorré K, Sarre S, Twahirwa E, Meeusen R, Ebinger G, Haemers A, Michotte Y (1996) Effect of L-tryptophan, L-5-hydroxytryptophan and L-tryptophan prodrugs on the extracellular levels of 5-HT and 5-HIAA in the hippocampus of the rat using microdialysis. Eur J Pharmac Sci 4: 247–256
Thorré K, Sarre S, Ebinger G, Michotte Y (1997) Characterization of extracellular serotonin release in the substantia nigra of freely moving rat using microdialysis. Brain Res (in press)
Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol Scand 367: 1–48
Van Veldhuizen MJA, Feenstra MGP, Boer GJ, Westerink BHC (1990) Microdialysis studies on cortical noradrenaline release: basic characteristics, significance of extracellular calcium and massive post-mortem increase. Neurosci Lett 119: 233–236
Verhagen-Kamerbeek WDJ, De Haas JRA, Teelken AW, Lakke JPWF (1991) In vivo assessment of the efficacy of L-threo-DOPS in producing extracellular noradrenaline in the CNS. In: Rollema H, Westerink BHC, Drijfhout WJ (eds) Monitoring molecules in neuroscience. University Centre for Pharmacy, Groningen, pp 409–412
Westerink BHC, De Vries J (1988) Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J Neurochem 51: 683–687
Wolf WA, Youdim MBH, Kuhn DM (1985) Does brain 5HIAA indicate serotonin release or monoamine oxidase activity? Eur J Pharmacol 109: 381–383
Zetterström T, Sharp T, Collin AK, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 148: 327–334
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarre, S., Smolders, I., Thorré, K. et al. Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: A microdialysis study. J. Neural Transmission 104, 1215–1228 (1997). https://doi.org/10.1007/BF01294722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294722